Clinical Trial Update: A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topiramate for weight loss and glycemic management in obese adults with type 2 diabetes on a controlled diet. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED